218 related articles for article (PubMed ID: 20352409)
1. A FRAX® model for the assessment of fracture probability in Belgium.
Johansson H; Kanis JA; McCloskey EV; Odén A; Devogelaer JP; Kaufman JM; Neuprez A; Hiligsmann M; Bruyere O; Reginster JY
Osteoporos Int; 2011 Feb; 22(2):453-61. PubMed ID: 20352409
[TBL] [Abstract][Full Text] [Related]
2. [A FRAX model for the assessment of fracture probability in Belgium].
Neuprez A; Johansson H; Kanis JA; McCloskey EV; Odén A; Bruyère O; Hiligsmann M; Devogelaer JP; Kaufman JM; Reginster JY
Rev Med Liege; 2009 Dec; 64(12):612-9. PubMed ID: 20143744
[TBL] [Abstract][Full Text] [Related]
3. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
[TBL] [Abstract][Full Text] [Related]
4. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX).
Fujiwara S; Nakamura T; Orimo H; Hosoi T; Gorai I; Oden A; Johansson H; Kanis JA
Osteoporos Int; 2008 Apr; 19(4):429-35. PubMed ID: 18292977
[TBL] [Abstract][Full Text] [Related]
5. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
[TBL] [Abstract][Full Text] [Related]
6. FRAX- vs. T-score-based intervention thresholds for osteoporosis.
Johansson H; Azizieh F; Al Ali N; Alessa T; Harvey NC; McCloskey E; Kanis JA
Osteoporos Int; 2017 Nov; 28(11):3099-3105. PubMed ID: 28782072
[TBL] [Abstract][Full Text] [Related]
7. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
[TBL] [Abstract][Full Text] [Related]
8. FRAX-based intervention thresholds for Pakistan.
Johansson H; Naureen G; Iqbal R; Jafri L; Khan AH; Umer M; Liu E; Vandenput L; Lorentzon M; McCloskey EV; Kanis JA; Harvey NC
Osteoporos Int; 2022 Jan; 33(1):105-112. PubMed ID: 34414463
[TBL] [Abstract][Full Text] [Related]
9. FRAX-based intervention and assessment thresholds for osteoporosis in Romania.
Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
Arch Osteoporos; 2013; 8():164. PubMed ID: 24390553
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.
Kanis JA; Harvey NC; Cooper C; Johansson H; Odén A; McCloskey EV;
Arch Osteoporos; 2016 Dec; 11(1):25. PubMed ID: 27465509
[TBL] [Abstract][Full Text] [Related]
11. The effects of a FRAX revision for the USA.
Kanis JA; Johansson H; Oden A; Dawson-Hughes B; Melton LJ; McCloskey EV
Osteoporos Int; 2010 Jan; 21(1):35-40. PubMed ID: 19705047
[TBL] [Abstract][Full Text] [Related]
12. FRAX-based fracture probabilities in South Africa.
Johansson H; Dela SS; Cassim B; Paruk F; Brown SL; Conradie M; Harvey NC; Jordaan JD; Kalla AA; Liu E; Lorentzon M; Lukhele M; McCloskey EV; Mohamed O; Chutterpaul P; Vandenput L; Kanis JA
Arch Osteoporos; 2021 Mar; 16(1):51. PubMed ID: 33649966
[TBL] [Abstract][Full Text] [Related]
13. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
Lippuner K
Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
[TBL] [Abstract][Full Text] [Related]
14. Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland.
Lippuner K; Johansson H; Borgström F; Kanis JA; Rizzoli R
Osteoporos Int; 2012 Nov; 23(11):2579-89. PubMed ID: 22222755
[TBL] [Abstract][Full Text] [Related]
15. FRAX assessment of osteoporotic fracture probability in Switzerland.
Lippuner K; Johansson H; Kanis JA; Rizzoli R
Osteoporos Int; 2010 Mar; 21(3):381-9. PubMed ID: 19517155
[TBL] [Abstract][Full Text] [Related]
16. FRAX® probabilities and risk of major osteoporotic fracture in France.
Couris CM; Chapurlat RD; Kanis JA; Johansson H; Burlet N; Delmas PD; Schott AM
Osteoporos Int; 2012 Sep; 23(9):2321-7. PubMed ID: 22179418
[TBL] [Abstract][Full Text] [Related]
17. Development and application of FRAX in the management of osteoporosis in Ireland.
McGowan B; Kanis JA; Johansson H; Silke C; Whelan B
Arch Osteoporos; 2013; 8():146. PubMed ID: 23982943
[TBL] [Abstract][Full Text] [Related]
18. Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry.
Leslie WD; Shevroja E; Johansson H; McCloskey EV; Harvey NC; Kanis JA; Hans D
Osteoporos Int; 2018 Mar; 29(3):751-758. PubMed ID: 29392355
[TBL] [Abstract][Full Text] [Related]
19. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model.
Lopez Gavilanez E; Johansson H; McCloskey E; Harvey NC; Segale Bajana A; Marriott Blum D; Navarro Grijalva M; Diaz Curiel M; Kanis JA
Arch Osteoporos; 2019 Aug; 14(1):93. PubMed ID: 31440846
[TBL] [Abstract][Full Text] [Related]
20. FRAX-based intervention and assessment thresholds in seven Latin American countries.
Clark P; Denova-Gutiérrez E; Zerbini C; Sanchez A; Messina O; Jaller JJ; Campusano C; Orces CH; Riera G; Johansson H; Kanis JA
Osteoporos Int; 2018 Mar; 29(3):707-715. PubMed ID: 29273826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
